Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|January 10, 2022
Biological Pathways Associated With the Development of Pulmonary Toxicities in Mesothelioma Patients Treated With Radical Hemithoracic Radiation Therapy: A Preliminary StudySergio Crovella, Alberto Revelant, Elena Muraro, et al.
Cancers|April 25, 2020
Dysmetabolic Circulating Tumor Cells Are Prognostic in Metastatic Breast CancerGiulia Brisotto, Eva Biscontin, Elisabetta Rossi, et al.
Cancer Immunology Research|March 25, 2016
Broadening Specificity and Enhancing Cytotoxicity of Adoptive T Cells for Nasopharyngeal Carcinoma ImmunotherapyDamiana Antonia Faè, Debora Martorelli, Katy Mastorci, et al.
Frontiers in Immunology|January 31, 2022
KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive Breast CancerElena Muraro, Mariangela De Zorzi, Gianmaria Miolo, et al.
Hematological Oncology|September 28, 2018
Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patientFrancesca Caccuri, Elena Muraro, Annunziata Gloghini, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2022
Emerging Role of Immunomonitoring to Predict the Clinical Outcome of Patients With Malignant Pleural Mesothelioma Treated With Radical Radiation TherapyMichela Cangemi, Marcella Montico, Marco Trovo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 26, 2017
Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trialMarco Trovo, Carlo Furlan, Jerry Polesel, et al.
Frontiers in Immunology|November 23, 2017
Local High-Dose Radiotherapy Induces Systemic Immunomodulating Effects of Potential Therapeutic Relevance in Oligometastatic Breast CancerElena Muraro, Carlo Furlan, Michele Avanzo, et al.
International Journal of Cancer|February 24, 2015
A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV settingDebora Martorelli, Elena Muraro, Katy Mastorci, et al.
Breast Cancer Research : BCR|November 25, 2011
A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapiesElena Muraro, Debora Martorelli, Elisa Turchet, et al.
Pageof 7